PRECISION OPTICS CORPORATION, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
PRECISION OPTICS CORPORATION, INC. (POCI) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $1.37 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2022-05-16
- 2022-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $1.37M.
- 2021-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $1.37M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2022-03-31 | $1.37M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.37M 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |